Stock Market News
SkinBioTherapeutics makes new patent filing for SkinBiotix
AIM-quoted life sciences company SkinBioTherapeutics has made a new patent filing for its SkinBiotix product.
SkinBiotix, designed to increase filaggrin levels in the skin, has been shown to significantly improve both the surface and inner layers of skin, suggesting that the technology will be "therapeutically useful" in a range of conditions, such as eczema.
The patent application follows a second successful test of SkinBiotix that proved the product can increase the "tight junction" within the inner layer of human skin.
Dr Cath O'Neill, SkinBioTherapeutics' chief executive, said, "SkinBiotix is continuing to prove its uniqueness as a platform via scientific testing. Following the successful work in skin models on fillagrin production, we are looking to increase the value and scope of our intellectual property with the filing of this patent."
"This is a continuation of our strategy to create an IP portfolio that allows us to robustly protect what we believe is a technology of significant commercial value in key global dermatological markets," O'Neill added.
As of 1010 BST, SkinBio shares had grown 3.44% to 16.55p.
SkinBiotix, designed to increase filaggrin levels in the skin, has been shown to significantly improve both the surface and inner layers of skin, suggesting that the technology will be "therapeutically useful" in a range of conditions, such as eczema.
The patent application follows a second successful test of SkinBiotix that proved the product can increase the "tight junction" within the inner layer of human skin.
Dr Cath O'Neill, SkinBioTherapeutics' chief executive, said, "SkinBiotix is continuing to prove its uniqueness as a platform via scientific testing. Following the successful work in skin models on fillagrin production, we are looking to increase the value and scope of our intellectual property with the filing of this patent."
"This is a continuation of our strategy to create an IP portfolio that allows us to robustly protect what we believe is a technology of significant commercial value in key global dermatological markets," O'Neill added.
As of 1010 BST, SkinBio shares had grown 3.44% to 16.55p.
Related share prices |
---|
SkinBioTherapeutics (SBTX) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price